Oragenics Inc. Files 8-K with Financial Statements
Ticker: OGEN · Form: 8-K · Filed: Aug 14, 2024 · CIK: 1174940
Sentiment: neutral
Topics: financial-reporting, exhibits
TL;DR
Oragenics filed an 8-K on Aug 14, 2024, mostly about financial statements and exhibits. No major news.
AI Summary
On August 14, 2024, Oragenics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosure related to the company's financial status and operations. No specific material events or transactions were detailed in the provided excerpt.
Why It Matters
This filing provides an update on Oragenics' financial reporting and exhibits, which is important for investors to assess the company's ongoing financial health and operational status.
Risk Assessment
Risk Level: low — The filing appears to be a routine disclosure of financial statements and exhibits, without any indication of significant negative events or material changes.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- August 14, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing by Oragenics, Inc.?
The primary purpose of this 8-K filing by Oragenics, Inc. is to report on 'Other Events' and 'Financial Statements and Exhibits'.
When was this 8-K report filed?
This 8-K report was filed on August 14, 2024.
What is Oragenics, Inc.'s principal executive office address?
Oragenics, Inc.'s principal executive office is located at 1990 Main Street, Suite 750, Sarasota, FL 34236.
What is Oragenics, Inc.'s telephone number?
Oragenics, Inc.'s telephone number is 813-286-7900.
What is Oragenics, Inc.'s state of incorporation?
Oragenics, Inc. is incorporated in Florida (FL).
Filing Stats: 445 words · 2 min read · ~1 pages · Grade level 11.4 · Accepted 2024-08-14 08:30:38
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 17KB
- 0001493152-24-031898.txt ( ) — 232KB
- ogen-20240814.xsd (EX-101.SCH) — 3KB
- ogen-20240814_lab.xml (EX-101.LAB) — 33KB
- ogen-20240814_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 14 th day of August, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer